cholecystokinin has been researched along with Hepatitis--Chronic* in 2 studies
2 other study(ies) available for cholecystokinin and Hepatitis--Chronic
| Article | Year |
|---|---|
Effects of homeopathic preparations on the liver in rats with acute and chronic toxic hepatitis.
Ultralow doses of antibodies to phenobarbital and their mixture (1:1) with ultralow doses of antibodies to cholecystokinin reduced the severity of structural and metabolic disturbances in the liver of rats with acute CCl4-induced hepatitis. The mixture of antibodies had no effect on the course of CCl4-induced hepatitis. Topics: Animals; Antibodies; Chemical and Drug Induced Liver Injury; Cholecystokinin; Dose-Response Relationship, Drug; Hepatitis, Chronic; Liver; Materia Medica; Phenobarbital; Rats; Rats, Wistar | 2003 |
Hepatoprotective properties of potentiated antibodies to cholecystokinin.
Ultralow doses of antibodies to cholecystokinin prevented hepatocyte death, delayed the formation of the connective tissue, and normalized plasma of liver enzyme in rats with experimental acute and chronic toxic hepatitis. Topics: Animals; Antibodies; Chemical and Drug Induced Liver Injury; Cholecystokinin; Hepatitis, Chronic; Liver; Rats; Rats, Wistar | 2003 |